BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15610604)

  • 1. Targeted adenovirus vectors.
    Mizuguchi H; Hayakawa T
    Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
    Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
    Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
    Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
    Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain.
    Kashentseva EA; Seki T; Curiel DT; Dmitriev IP
    Cancer Res; 2002 Jan; 62(2):609-16. PubMed ID: 11809717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of high-capacity adenoviral vectors.
    Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
    Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.
    Li J; Lad S; Yang G; Luo Y; Iacobelli-Martinez M; Primus FJ; Reisfeld RA; Li E
    J Virol; 2006 Dec; 80(24):12324-31. PubMed ID: 17020947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
    Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
    Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
    Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
    Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T
    J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.
    Cripe TP; Dunphy EJ; Holub AD; Saini A; Vasi NH; Mahller YY; Collins MH; Snyder JD; Krasnykh V; Curiel DT; Wickham TJ; DeGregori J; Bergelson JM; Currier MA
    Cancer Res; 2001 Apr; 61(7):2953-60. PubMed ID: 11306473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
    Mizuguchi H; Koizumi N; Hosono T; Utoguchi N; Watanabe Y; Kay MA; Hayakawa T
    Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient regulation of gene expression using self-contained fiber-modified adenovirus vectors containing the tet-off system.
    Mizuguchi H; Xu ZL; Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T
    J Control Release; 2005 Dec; 110(1):202-11. PubMed ID: 16278030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
    Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
    Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
    Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A system for the propagation of adenoviral vectors with genetically modified receptor specificities.
    Douglas JT; Miller CR; Kim M; Dmitriev I; Mikheeva G; Krasnykh V; Curiel DT
    Nat Biotechnol; 1999 May; 17(5):470-5. PubMed ID: 10331807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
    Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
    Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
    Nakamura T; Sato K; Hamada H
    J Virol; 2003 Feb; 77(4):2512-21. PubMed ID: 12551989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Adenovirus Gene Transfer Methods in Human Colonic Caco-2 Epithelial Cells Using Capric Acid.
    Koizumi N; Yamagishi Y; Hirai T; Fujii M; Mizuguchi H; Watanabe Y
    Biol Pharm Bull; 2015; 38(8):1240-4. PubMed ID: 26235589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin.
    Krasnykh V; Belousova N; Korokhov N; Mikheeva G; Curiel DT
    J Virol; 2001 May; 75(9):4176-83. PubMed ID: 11287567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
    Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
    Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.